Integrations
Services
Company
FUNDRAISING NEWS | December 18, 2024
Tags: Private Equity, Venture Capital, Fundraising
Life sciences-focused venture capital firm XGEN Venture secured €180M (~$188.5M) in capital commitments at the final close of its first life sciences fund.
XGEN Venture Life Sciences Fund generated pledges from institutional investors, family offices and high-net-worth individuals. It targets early-stage investments in biotechnology, medical devices and diagnostics.
The fund has so far invested in six startups including clinical-stage biopharmaceutical company iOnctura. Over the next two to three years, it intends to complete its portfolio, with nine more investments planned.
Written By: Dakota
925 West Lancaster Ave
Suite 220
Bryn Mawr, PA 19010
Tel: (610) 642-1481
© Dakota 2025 | Terms of Use | Privacy Policy